Follow us on X: @ERINHA_RI
You can contact us here
Access to our intranet here
Download our portfolio here
The joint EDCTP and CEPI call on “Vaccines against Lassa virus disease” was launched to support distinct strategic actions (clinical research activities) which are part of efforts to prepare and conduct a large-scale clinical trial. The goal is to achieve proof of concept and/or demonstrate the efficacy of novel candidate vaccines against Lassa virus (LASV).
ERINHA AISBL
98, rue du Trône / Boîte n°4
B-1050 Bruxelles
ERINHA AISBL CCU
101, rue Tolbiac – 75013 Paris
Subscribe for latest articles and resources